CDH1 and head and neck squamous cell carcinoma: HNSCC cells were subsequently treated with IL-6, which significantly upregulated the expression of p-ERK and downregulated the epithelial marker E-cadherin, similar to the effects observed with FbCM treatment (Figure 2A,B and Figure S2C,D).